NFKB1 and plasma cell myeloma: Curcumin diminishes the viability and survival rate of leukemia, myeloma, and lymphoma cells by inducing cell cycle arrest and apoptosis, and it inhibits molecular pathways linked to tumor progression such as NFKB, STAT, Akt/PI3K, and MEK/ERK [387,389,390,391].